ATE485299T1 - Tricyclische benzopyranverbindungen als antiarrhythmika - Google Patents

Tricyclische benzopyranverbindungen als antiarrhythmika

Info

Publication number
ATE485299T1
ATE485299T1 AT05727581T AT05727581T ATE485299T1 AT E485299 T1 ATE485299 T1 AT E485299T1 AT 05727581 T AT05727581 T AT 05727581T AT 05727581 T AT05727581 T AT 05727581T AT E485299 T1 ATE485299 T1 AT E485299T1
Authority
AT
Austria
Prior art keywords
group
hydrogen atom
ring
atom
bond
Prior art date
Application number
AT05727581T
Other languages
German (de)
English (en)
Inventor
Kazuhiko Ohrai
Yukihiro Shigeta
Osamu Uesugi
Takumi Okada
Tomoyuki Matsuda
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE485299T1 publication Critical patent/ATE485299T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05727581T 2004-03-23 2005-03-23 Tricyclische benzopyranverbindungen als antiarrhythmika ATE485299T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
PCT/JP2005/006004 WO2005090357A1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Publications (1)

Publication Number Publication Date
ATE485299T1 true ATE485299T1 (de) 2010-11-15

Family

ID=34962589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05727581T ATE485299T1 (de) 2004-03-23 2005-03-23 Tricyclische benzopyranverbindungen als antiarrhythmika

Country Status (30)

Country Link
US (2) US7652008B2 (cg-RX-API-DMAC7.html)
EP (1) EP1732929B1 (cg-RX-API-DMAC7.html)
JP (1) JP4840594B2 (cg-RX-API-DMAC7.html)
KR (2) KR101019402B1 (cg-RX-API-DMAC7.html)
CN (3) CN102190661B (cg-RX-API-DMAC7.html)
AT (1) ATE485299T1 (cg-RX-API-DMAC7.html)
AU (2) AU2005223612B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0508768A (cg-RX-API-DMAC7.html)
CA (1) CA2558139C (cg-RX-API-DMAC7.html)
CY (1) CY1111250T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2006598A3 (cg-RX-API-DMAC7.html)
DE (1) DE602005024245D1 (cg-RX-API-DMAC7.html)
DK (1) DK1732929T3 (cg-RX-API-DMAC7.html)
EG (1) EG27163A (cg-RX-API-DMAC7.html)
ES (1) ES2353021T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20110005T1 (cg-RX-API-DMAC7.html)
IL (1) IL177950A (cg-RX-API-DMAC7.html)
MX (1) MXPA06010880A (cg-RX-API-DMAC7.html)
NO (1) NO339495B1 (cg-RX-API-DMAC7.html)
NZ (2) NZ549570A (cg-RX-API-DMAC7.html)
PL (1) PL1732929T3 (cg-RX-API-DMAC7.html)
PT (1) PT1732929E (cg-RX-API-DMAC7.html)
RS (1) RS51742B (cg-RX-API-DMAC7.html)
RU (1) RU2380370C2 (cg-RX-API-DMAC7.html)
SI (1) SI1732929T1 (cg-RX-API-DMAC7.html)
SK (1) SK287994B6 (cg-RX-API-DMAC7.html)
TW (1) TWI352704B (cg-RX-API-DMAC7.html)
UA (1) UA91189C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005090357A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200607388B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4840594B2 (ja) * 2004-03-23 2011-12-21 日産化学工業株式会社 抗不整脈薬としての3環性ベンゾピラン化合物
US8394974B2 (en) 2006-03-10 2013-03-12 Nissan Chemical Industries, Ltd. Process for producing optically active chromene oxide compound
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物
AR076524A1 (es) * 2009-04-30 2011-06-15 Nissan Chemical Ind Ltd Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la misma
PT2445502T (pt) 2009-06-25 2017-09-22 Alkermes Pharma Ireland Ltd Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
US9738654B2 (en) 2012-09-27 2017-08-22 Nissan Chemical Industries, Ltd. Method for producing nitrogen-containing heterocyclic N-oxide compound
CN104507949B (zh) * 2012-09-27 2017-07-28 日产化学工业株式会社 高纯度的含氮杂环化合物的制造方法
CN105377826A (zh) * 2013-07-25 2016-03-02 日产化学工业株式会社 杂环化合物的制造方法
CN110177796B (zh) * 2017-01-06 2022-04-08 阿斯克里斯有限公司 喹啉酮衍生物及其用于预防或治疗变应性疾病的药物组合物
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
CN113543849B (zh) * 2018-12-28 2025-03-21 国立大学法人大阪大学 遗传性缓慢性心律失常治疗药
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
JP7733887B2 (ja) * 2020-06-26 2025-09-04 国立大学法人大阪大学 薬剤誘発性徐脈および徐脈性不整脈治療薬

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JPH0699439B2 (ja) 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
US5097037A (en) 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
EP0693283A4 (en) 1993-04-02 1997-07-23 Nissan Chemical Ind Ltd REMEDY FOR HEART FAILURE
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
EP0764159B1 (en) 1994-06-10 2000-08-09 Smithkline Beecham Plc C -4 amide substituted compounds and their use as therapeutic agents
TW496866B (en) * 1996-05-15 2002-08-01 Hoechst Ag Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them
WO1999062867A1 (fr) 1998-06-03 1999-12-09 Nissan Chemical Industries, Ltd. Derives d'indane
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
AU2830800A (en) 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
WO2001021610A1 (en) 1999-09-17 2001-03-29 Nissan Chemical Industries, Ltd. Benzopyran derivative
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
IL159218A0 (en) 2001-06-25 2004-06-01 Nissan Chemical Ind Ltd Substituted benzopyran derivatives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
JP4840594B2 (ja) * 2004-03-23 2011-12-21 日産化学工業株式会社 抗不整脈薬としての3環性ベンゾピラン化合物

Also Published As

Publication number Publication date
DK1732929T3 (da) 2010-12-20
US20100069374A1 (en) 2010-03-18
NZ585606A (en) 2011-11-25
UA91189C2 (en) 2010-07-12
SK287994B6 (sk) 2012-09-03
PT1732929E (pt) 2010-12-21
CA2558139C (en) 2012-01-17
NZ549570A (en) 2010-08-27
HRP20110005T1 (hr) 2011-02-28
WO2005090357A1 (en) 2005-09-29
US7964623B2 (en) 2011-06-21
CN1934116B (zh) 2012-10-10
TW200600509A (en) 2006-01-01
SK50792006A3 (sk) 2007-09-06
RS51742B (sr) 2011-10-31
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
AU2010202900B2 (en) 2011-10-27
AU2005223612A1 (en) 2005-09-29
IL177950A (en) 2013-04-30
AU2005223612B2 (en) 2010-06-24
KR101085979B1 (ko) 2011-11-22
BRPI0508768A (pt) 2007-02-27
MXPA06010880A (es) 2006-12-15
KR20070009638A (ko) 2007-01-18
CN102190661B (zh) 2013-07-31
CN101429200B (zh) 2012-05-30
NO339495B1 (no) 2016-12-19
CY1111250T1 (el) 2015-06-11
JP2007530436A (ja) 2007-11-01
SI1732929T1 (sl) 2010-12-31
NO20064819L (no) 2006-10-23
EP1732929B1 (en) 2010-10-20
ES2353021T3 (es) 2011-02-24
AU2010202900A1 (en) 2010-07-29
CA2558139A1 (en) 2005-09-29
EP1732929A1 (en) 2006-12-20
CN1934116A (zh) 2007-03-21
IL177950A0 (en) 2006-12-31
EG27163A (en) 2015-08-24
JP4840594B2 (ja) 2011-12-21
PL1732929T3 (pl) 2011-04-29
DE602005024245D1 (de) 2010-12-02
CZ2006598A3 (cs) 2006-11-15
RU2006137284A (ru) 2008-04-27
US7652008B2 (en) 2010-01-26
HK1099299A1 (en) 2007-08-10
TWI352704B (en) 2011-11-21
CN102190661A (zh) 2011-09-21
CN101429200A (zh) 2009-05-13
US20080004262A1 (en) 2008-01-03
RU2380370C2 (ru) 2010-01-27
ZA200607388B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
CY1111250T1 (el) Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων
MY139988A (en) Macrocylic inhibitors of hepatitis c virus
HUP0300138A2 (en) Cyclic amine derivatives as ccr5 antagonists, their production and use and pharmaceutical compositions containing them
CY1109222T1 (el) Παραγωγο συγχωνευμενης κινολινης και χρηση του
YU79502A (sh) Novi,sporodelujući betamimetici,postupak za njihovo pripremanje i njihova primena kao lekova
EP1719761A4 (en) NEW HETEROCYCLIC CONNECTION
AP2003002841A0 (en) Quinazolines as MMP-13 inhibitors
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
SG163617A1 (en) Macrocyclic inhibitors of hepatitis c virus
BG105969A (en) Amine derivatives as protein inhibitors
WO2003057669A1 (fr) Antagonistes du recepteur androgene
MX9504287A (es) Derivados de camptotecina y proceso para su preparacion.
ES2164164T3 (es) Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa.
NZ505927A (en) Cyclobutene-1,2-dione derivatives for use in the inhibition of an ileal bile acid transporter
ATE191716T1 (de) Benzopyran und benzoxazin-derivate
ES2199696A1 (es) Mezclas de estabilizantes
EP1070715A4 (en) Arylpiperidine derivatives and use thereof
ATE214059T1 (de) 4,6-di-t-butyl-2,3-dihydrobenzothiophene, die ldl oxidation hemmen
MXPA02007973A (es) Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece.
IL136510A (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
DE60106168D1 (de) Substituierte 1-aza-2-imino-heterocyclen und ihre verwendung als aktivatoren der nikotinergen acetylcholinrezeptoren
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
DK1546096T3 (da) Fremgangsmåde til fremstilling af aminopyrrolidinderivater
DE60008396D1 (de) Amidderivate
DE60221894D1 (de) Vollständige synthese der galanthamin, deren analogen und derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1732929

Country of ref document: EP